Replicel Life Sciences Stock Buy Hold or Sell Recommendation
| RP Stock | CAD 0.01 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding RepliCel Life Sciences is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell RepliCel Life Sciences given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for RepliCel Life Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out RepliCel Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as RepliCel and provide practical buy, sell, or hold advice based on investors' constraints. RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
RepliCel |
Execute RepliCel Life Buy or Sell Advice
The RepliCel recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on RepliCel Life Sciences. Macroaxis does not own or have any residual interests in RepliCel Life Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute RepliCel Life's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
RepliCel Life Trading Alerts and Improvement Suggestions
| RepliCel Life generated a negative expected return over the last 90 days | |
| RepliCel Life has high historical volatility and very poor performance | |
| RepliCel Life has some characteristics of a very speculative penny stock | |
| RepliCel Life has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 353.74 K. Net Loss for the year was (311.73 K) with profit before overhead, payroll, taxes, and interest of 353.74 K. | |
| RepliCel Life Sciences currently holds about 1.16 M in cash with (1.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 59.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: RepliCel Life Sciences Urges Online Access for Shareholders - TipRanks |
RepliCel Life Returns Distribution Density
The distribution of RepliCel Life's historical returns is an attempt to chart the uncertainty of RepliCel Life's future price movements. The chart of the probability distribution of RepliCel Life daily returns describes the distribution of returns around its average expected value. We use RepliCel Life Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of RepliCel Life returns is essential to provide solid investment advice for RepliCel Life.
| Mean Return | -0.74 | Value At Risk | -33.33 | Potential Upside | 0.00 | Standard Deviation | 21.02 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of RepliCel Life historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
RepliCel Life Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (2.4M) | 10.4K | 186.8K | 191.8K | (353.9K) | (336.2K) | |
| Free Cash Flow | (2.8M) | (765.2K) | (2.5M) | (1.4M) | (1.4M) | (1.5M) | |
| Other Non Cash Items | (285.1K) | (281.1K) | 560.6K | (1.6M) | (1.1M) | (1.0M) | |
| Net Income | (3.0M) | (1.6M) | (4.1M) | (743.2K) | (311.7K) | (327.3K) | |
| End Period Cash Flow | 23.9K | 34.4K | 221.2K | 413.0K | 59.2K | 56.2K | |
| Depreciation | 2.2K | 1.6K | 1.1K | 839.0 | 1.5K | 1.4K | |
| Change To Netincome | 232.2K | (224.8K) | (102.5K) | 1.9M | 2.2M | 2.3M |
RepliCel Life Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to RepliCel Life or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that RepliCel Life's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a RepliCel stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.84 | |
β | Beta against Dow Jones | 1.55 | |
σ | Overall volatility | 21.53 | |
Ir | Information ratio | -0.04 |
RepliCel Life Volatility Alert
RepliCel Life Sciences is displaying above-average volatility over the selected time horizon. RepliCel Life Sciences is a penny stock. Although RepliCel Life may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in RepliCel Life Sciences. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on RepliCel instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.RepliCel Life Fundamentals Vs Peers
Comparing RepliCel Life's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze RepliCel Life's direct or indirect competition across all of the common fundamentals between RepliCel Life and the related equities. This way, we can detect undervalued stocks with similar characteristics as RepliCel Life or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of RepliCel Life's fundamental indicators could also be used in its relative valuation, which is a method of valuing RepliCel Life by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare RepliCel Life to competition |
| Fundamentals | RepliCel Life | Peer Average |
| Return On Asset | -1.53 | -0.14 |
| Profit Margin | 2.16 % | (1.27) % |
| Operating Margin | (0.74) % | (5.51) % |
| Current Valuation | 744.26 K | 16.62 B |
| Shares Outstanding | 73.58 M | 571.82 M |
| Shares Owned By Insiders | 59.39 % | 10.09 % |
| Number Of Shares Shorted | 520 | 4.71 M |
| Price To Earning | (1.05) X | 28.72 X |
| Price To Sales | 2.08 X | 11.42 X |
| Revenue | 353.74 K | 9.43 B |
| Gross Profit | 353.74 K | 27.38 B |
| EBITDA | (1.38 M) | 3.9 B |
| Net Income | (311.73 K) | 570.98 M |
| Cash And Equivalents | 1.16 M | 2.7 B |
| Cash Per Share | 0.04 X | 5.01 X |
| Total Debt | 813.19 K | 5.32 B |
| Current Ratio | 2.09 X | 2.16 X |
| Book Value Per Share | (0.07) X | 1.93 K |
| Cash Flow From Operations | (1.41 M) | 971.22 M |
| Short Ratio | 0.01 X | 4.00 X |
| Earnings Per Share | (0.02) X | 3.12 X |
| Target Price | 1.64 | |
| Beta | 0.95 | -0.15 |
| Market Capitalization | 735.78 K | 19.03 B |
| Total Asset | 287.79 K | 29.47 B |
| Retained Earnings | (43.29 M) | 9.33 B |
| Working Capital | (1.44 M) | 1.48 B |
| Net Asset | 287.79 K |
RepliCel Life Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as RepliCel . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About RepliCel Life Buy or Sell Advice
When is the right time to buy or sell RepliCel Life Sciences? Buying financial instruments such as RepliCel Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having RepliCel Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Realty Funds Thematic Idea Now
Realty Funds
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.